http://orcid.org/0000-0003-1042-6024
Citations (30)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Kanjaksha Ghosh & Kinjalka Ghosh. (2022) Monoclonal antibodies used for the management of hemataological disorders. Expert Review of Hematology 15:5, pages 443-455.
Read now
Read now
Articles from other publishers (29)
Ruihua Mi, Lin Chen, Lin Wang & Xudong Wei. (2023) Bone marrow necrosis after treatment with blinatumomab for acute lymphoblastic leukemia: A case report. Asian Journal of Surgery.
Crossref
Crossref
Frederike Kramer & Ann Mullally. (2023) Antibody targeting of mutant calreticulin in myeloproliferative neoplasms. Journal of Cellular and Molecular Medicine.
Crossref
Crossref
Jiao Xie, Suxiang Liu, Ming Zhou, Yi Wang, Hailong He, Peifang Xiao, Shaoyan Hu & Jun Lu. (2023) Short-course blinatumomab for refractory/relapse precursor B acute lymphoblastic leukemia in children. Frontiers in Pediatrics 11.
Crossref
Crossref
C. Collignon, C. Domenech, S. Ducassou, C. Pluchart, B. Bruno, M. Pasquet, P. Simon, A. Petit, F. Rialland‐Battisti & B. Brethon. (2023) Temporary contraindication to chemotherapy due to toxicity: blinatumomab's effectiveness in paediatric patients with B‐acute lymphoblastic leukaemia. British Journal of Haematology 201:4.
Crossref
Crossref
Dingkang Liu, Lichen Bao, Haichao Zhu, Yali Yue, Jing Tian, Xiangdong Gao & Jun Yin. (2023) Microenvironment-responsive anti-PD-L1 × CD3 bispecific T-cell engager for solid tumor immunotherapy. Journal of Controlled Release 354, pages 606-614.
Crossref
Crossref
Young Hoon Park & Dong Jin Park. (2022) Treatment of CD19-Positive Mixed Phenotype Acute Leukemia with Blinatumomab. The Korean Journal of Medicine 97:1, pages 60-63.
Crossref
Crossref
Diana V. Maslov & Ambuga Badari. (2021) Pericardial Relapse of Acute Lymphoblastic Leukemia (ALL). Case Reports in Oncological Medicine 2021, pages 1-3.
Crossref
Crossref
Zachery Halford, Carli Coalter, Vanessa Gresham & Tabitha Brown. (2021) A Systematic Review of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Engaging an Old Problem With New Solutions. Annals of Pharmacotherapy 55:10, pages 1236-1253.
Crossref
Crossref
Simona Sivori, Daniela Pende, Linda Quatrini, Gabriella Pietra, Mariella Della Chiesa, Paola Vacca, Nicola Tumino, Francesca Moretta, Maria Cristina Mingari, Franco Locatelli & Lorenzo Moretta. (2021) NK cells and ILCs in tumor immunotherapy. Molecular Aspects of Medicine 80, pages 100870.
Crossref
Crossref
Reza Moazzami, Hasan Mirzahoseini, Leila Nematollahi, Farzaneh Barkhordari, Mozhgan Raigani, Fatemeh Hajari Taheri, Fereidoun Mahbudi & Fatemeh Davami. (2021) Woodchuck Hepatitis Virus Post-Transcriptional Regulation Element (WPRE) Promotes Anti-CD19 BiTE Expression in Expi293 Cells. Iranian Biomedical Journal 25:4, pages 275-283.
Crossref
Crossref
Kanjaksha GhoshKinjalka Ghosh. (2021) Monoclonal antibodies used for management of hematological disorders. Journal of Hematology and Allied Sciences 1, pages 12-21.
Crossref
Crossref
Nese Yarali, Melek Isik, Ozlem Arman-Bilir, Zeliha Guzelkucuk & Ayse Selcen Oguz-Erdogan. (2020) Bone Marrow Necrosis in a Patient Following Blinatumomab Therapy. Journal of Pediatric Hematology/Oncology 42:3, pages e167-e169.
Crossref
Crossref
Cinnie Yentia Soekojo, Melissa Ooi, Sanjay de Mel & Wee Joo Chng. (2020) Immunotherapy in Multiple Myeloma. Cells 9:3, pages 601.
Crossref
Crossref
Aneela Majeed, Zoey Harris, Eric Brucks, Alyssa Hinchman, Arafat Ali Farooqui, Muhammad Junaid Tariq, Kavin Tamizhmani, Irbaz bin Riaz, Ali McBride, Azka Latif, Vikas Kapoor, Raheel Iftikhar, Sherif Mossad & Faiz Anwer. (2020) Revisiting Role of Vaccinations in Donors, Transplant Recipients, Immunocompromised Hosts, Travelers, and Household Contacts of Stem Cell Transplant Recipients. Biology of Blood and Marrow Transplantation 26:2, pages e38-e50.
Crossref
Crossref
Carolina Simioni, Fabio Bergamini, Martina Ferioli, Erika Rimondi, Lorenzo Caruso & Luca M. Neri. (2019) New biomarkers and therapeutic strategies in acute lymphoblastic leukemias: Recent advances. Hematological Oncology 38:1, pages 22-33.
Crossref
Crossref
Jose-Maria Ribera, Eulalia Genescà & Jordi Ribera. (2020) Bispecific T-cell engaging antibodies in B-cell precursor acute lymphoblastic leukemias: focus on blinatumomab. Therapeutic Advances in Hematology 11, pages 204062072091963.
Crossref
Crossref
Shipra Gandhi, Aman Gupta, Pankit Vachhani,Igor Puzanov & Marc S. Ernstoff. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities
259
276
.
Shipra Gandhi, Aman Gupta & Marc S. Ernstoff. 2020. Handbook of Cancer Treatment-Related Symptons and Toxicities. Handbook of Cancer Treatment-Related Symptons and Toxicities
201
222
.
Dalma Deak, Cristina Pop, Alina-Andreea Zimta, Ancuta Jurj, Alexandra Ghiaur, Sergiu Pasca, Patric Teodorescu, Angela Dascalescu, Ion Antohe, Bogdan Ionescu, Catalin Constantinescu, Anca Onaciu, Raluca Munteanu, Ioana Berindan-Neagoe, Bobe Petrushev, Cristina Turcas, Sabina Iluta, Cristina Selicean, Mihnea Zdrenghea, Alina Tanase, Catalin Danaila, Anca Colita, Andrei Colita, Delia Dima, Daniel Coriu, Hermann Einsele & Ciprian Tomuleasa. (2019) Let’s Talk About BiTEs and Other Drugs in the Real-Life Setting for B-Cell Acute Lymphoblastic Leukemia. Frontiers in Immunology 10.
Crossref
Crossref
Jasmine Davda, Paul Declerck, Siwen Hu-Lieskovan, Timothy P. Hickling, Ira A. Jacobs, Jeffrey Chou, Shahram Salek-Ardakani & Eugenia Kraynov. (2019) Immunogenicity of immunomodulatory, antibody-based, oncology therapeutics. Journal for ImmunoTherapy of Cancer 7:1.
Crossref
Crossref
Simona Sivori, Raffaella Meazza, Concetta Quintarelli, Simona Carlomagno, Mariella Della Chiesa, Michela Falco, Lorenzo Moretta, Franco Locatelli & Daniela Pende. (2019) NK Cell-Based Immunotherapy for Hematological Malignancies. Journal of Clinical Medicine 8:10, pages 1702.
Crossref
Crossref
Peter Valent, Irina Sadovnik, Gregor Eisenwort, Karin Bauer, Harald Herrmann, Karoline V. Gleixner, Axel Schulenburg, Werner Rabitsch, Wolfgang R. Sperr & Dominik Wolf. (2019) Immunotherapy-Based Targeting and Elimination of Leukemic Stem Cells in AML and CML. International Journal of Molecular Sciences 20:17, pages 4233.
Crossref
Crossref
Valentina Sas, Vlad Moisoiu, Patric Teodorescu, Sebastian Tranca, Laura Pop, Sabina Iluta, Sergiu Pasca, Cristina Blag, Sorin Man, Andrei Roman, Catalin Constantinescu, Ioana Rus, Mihail Buse, Bogdan Fetica, Mirela Marian, Cristina Selicean, Ioana Berindan-Neagoe, Bobe Petrushev, Horia Bumbea, Alina Tanase, Mihnea Zdrenghea, Shigeo Fuji, Shigehisa Kitano & Ciprian Tomuleasa. (2019) Approach to the Adult Acute Lymphoblastic Leukemia Patient. Journal of Clinical Medicine 8:8, pages 1175.
Crossref
Crossref
Yu. Yu. Dyakonova, N. V. Myakova, D. V. Litvinov, L. N. Shelikhova, M. A. Maschan, Yu. G. Abugova, V. V. Fominykh, D. A. Yevstratov, O. I. Bydanov, E. E. Kurnikova, A. M. Popov, Yu. V. Olshanskaya & А. I. Karachunsky. (2019) First results of pilot protocol ALl-REZ-2016 for children with high risk groups of relapsed acute lymphoblastic leukemia. Pediatric Hematology/Oncology and Immunopathology 18:1, pages 12-21.
Crossref
Crossref
Peter H. Wiernik. (2019) Adult hypodiploid B‐acute lymphoblastic leukaemia and stem cell transplantation. British Journal of Haematology.
Crossref
Crossref
Carolina Simioni, Alberto Martelli, Giorgio Zauli, Elisabetta Melloni & Luca Neri. (2019) Targeting mTOR in Acute Lymphoblastic Leukemia. Cells 8:2, pages 190.
Crossref
Crossref
Amanda C. Herrmann, Jin S. Im, Sumedha Pareek, Wilfredo Ruiz-Vasquez, Sijie Lu, Anna Sergeeva, Jennifer Mehrens, Hong He, Gheath Alatrash, Pariya Sukhumalchandra, Lisa St. John, Karen Clise-Dwyer, Dongxing Zha & Jeffrey J. Molldrem. (2019) A Novel T-Cell Engaging Bi-specific Antibody Targeting the Leukemia Antigen PR1/HLA-A2. Frontiers in Immunology 9.
Crossref
Crossref
Sergei Nikolaevich Bondarenko, E.N. Parovichnikova, A.A. Maschan, O.Yu. Baranova, T.V. Shelekhovas, V.A. Doronin, V.Ya. Mel'nichenko, K.D. Kaplanov, O.S. Uspenskaya, A.N. Sokolov, N.V. Myakova, I.S. Moiseev, I.V. Markova, E.I. Darskaya, A.G. Smirnova, T.A. Bykova, B.I. Ayubova, I.A. Samorodova, E.V. Babenko, I.M. Barkhatov, T.L. Gindina, A.D. Kulagin & B.V. Afanas'ev. (2019) Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Russian Multicenter Clinical Trial. Clinical oncohematology 12:2, pages 45-53.
Crossref
Crossref
Jean El-Cheikh, Nour M. Moukalled, Haidar El Darsa, Radwan Massoud, Souha S. Kanj, Rami Mahfouz & Ali Bazarbachi. (2018) Feasibility of the Combination of Venetoclax and Asparaginase-based Chemotherapy for Adult Patients With Relapsed/Refractory Acute Lymphoblastic Leukemia. Clinical Lymphoma Myeloma and Leukemia 18:10, pages e441-e444.
Crossref
Crossref